CDSCO Approves Metformin Use in Pregnancy and Peri-Conceptional Phase
Written By : Dr. Nandita Mohan
Published On 2025-02-15 06:30 GMT | Update On 2025-02-15 07:30 GMT
Advertisement
The Endocrinology and Metabolism Subject Expert Committee (SEC) under CDSCO has approved updating the prescribing information for Metformin Hydrochloride SR Tablets (500 mg and 1000 mg), enabling its use during pregnancy and the peri-conceptional phase based on the discretion of treating physicians.
As part of this update, the following statement will be added to the prescribing information
"If clinically needed, the use of Metformin can be considered during pregnancy and in the peri-conceptional phase as an addition or an alternative to insulin based on treating physician discretion."
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.